News

AACR Annual Meeting 2016: Can a Universal Adaptor Overcome CAR T-cell Immunotherapy Limitations?
April 27, 2016

In a study presented at the AACR Annual Meeting 2016 on April 19, researchers engineered an organic bispecific adaptor molecule that can serve as a bridge between a chimeric antigen receptor (CAR) T cell and a cancer cell, and, using animal models, demonstrated how this adaptor can potentially overcome some of the limitations posed by CAR T-cell immunotherapy technologies.

Purdue research may expand engineered T-cell cancer treatment
April 22, 2016

Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."

Research Could Expand Engineered T-Cell Cancer Treatment
April 21, 2016

Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."

Purdue research may expand engineered T-cell cancer treatment
April 20, 2016

Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."

AACR 2016: New technology can potentially overcome CAR T-cell immunotherapy limitations
April 19, 2016

An engineered organic bispecific adaptor molecule that functions as a bridge between a chimeric antigen receptor (CAR) T cell and a cancer cell can potentially overcome some of the limitations posed by CAR T-cell immunotherapy technologies, according to data presented at the AACR Annual Meeting 2016.

New Technology Can Potentially Overcome CAR T-cell Immunotherapy Limitations
April 19, 2016

An engineered organic bispecific adaptor molecule that functions as a bridge between a chimeric antigen receptor (CAR) T cell and a cancer cell can potentially overcome some of the limitations posed by CAR T-cell immunotherapy technologies, according to data presented here at the AACR Annual Meeting 2016, April 16-20.

Center for Drug Discovery solidifying team with faculty hires
September 9, 2015

Less than a year after it was officially dedicated, the Center for Drug Discovery is running at nearly full strength. Dozens of researchers are creating new methods to combat cancer, diabetes and many of the worlds deadliest infectious diseases.

New faculty, fall 2015
August 14, 2015

Welcome to the following new Purdue faculty members, who have joined the Center for Drug Discovery.

BTN LiveBIG: From the basketball court to the lab, Big Ten fights cancer
February 9, 2015

A couple of weeks ago, basketball coaches across the Big Ten Conference made a fashion statement of sorts. They donned snazzy sneakers on the hardwood, even though many of them were wearing suits and ties, to take part in Coaches vs. Cancer, a nationwide campaign that annually draws public attention to advocacy and fundraising efforts around this severe disease.

Three Purdue professors elected as fellows of National Academy of Inventors
December 17, 2014

Three Purdue University professors have been named fellows of the National Academy of Inventors. The organization recognized Jan P. Allebach, the Hewlett-Packard Distinguished Professor of Electrical and Computer Engineering; R. Graham Cooks, the Henry Bohn Hass Distinguished Professor of Chemistry; and Philip S. Low, the Ralph C. Corley Distinguished Professor of Chemistry. The three are among 170 new fellows "who have demonstrated a prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development and the welfare of society," according to a statement from the NAI.